Sickle cell leg ulcers: A frequently disabling complication and a marker of severity

British Journal of Dermatology

Volumn 158, Issue 2, 2008, Pages 339-344

  Halabi Tawil, M ^a   Lionnet, F ^a   Girot, R ^a   Bachmeyer, C ^c   Levy P P ^a   Aractingi, S ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c NONE

Author keywords

Characteristics; Complications; Quality of life; Short Form 36 Health Survey; Sickle cell disease; Ulcers

Indexed keywords

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DISEASE SURVEILLANCE; FEMALE; HUMAN; LEG ULCER; MALE; MOOD DISORDER; PRIAPISM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; SCHOOL CHILD; SCORING SYSTEM; SHORT FORM 36; SICKLE CELL; STROKE; WOUND INFECTION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANKLE JOINT; CHILD; DERMATITIS; FEMALE; FRANCE; HUMANS; INFECTION; LEG ULCER; MALE; MOOD DISORDERS; QUALITY OF LIFE; RISK FACTORS;

EID: 38349124141     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08323.x     Document Type: Article

References (27)

1. Chaine B, Neonato MG, Girot R, Aractingi S. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol 2001 137 : 467 70.
2. Koshy M, Entsuah R, Koranda A et al. Leg ulcers in patients with sickle cell disease. Blood 1989 74 : 1403 8.
3. Mery L, Girot R, Aractingi S. Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers. Dermatology 2004 208 : 135 7.
4. Nolan VG, Adewoye A, Baldwin C et al. Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta pathway. Br J Haematol 2006 133 : 570 8.
5. Eckman JR. Leg ulcers in sickle cell disease. Hematol Oncol Clin North Am 1996 10 : 1333 44.
6. Trent JT, Kirsner R. Leg ulcers in sickle cell disease. Adv Skin Wound Care 2004 17 : 410 16.
7. Ballas SK. Sickle cell anemia: progress in pathogenesis and treatment. Drugs 2002 62 : 1143 72.
8. Ademiluyi SA, Rotimi VO, Coker AO et al. The anaerobic and aerobic bacterial flora of leg ulcers in patients with sickle cell disease. J Infect 1988 17 : 115 20.
9. Serjeant GR. Leg ulceration in sickle cell anemia. Arch Intern Med 1974 133 : 690 4.
10. Morgan AG. Sickle cell leg ulcers. Int J Dermatol 1985 24 : 643 4.
11. Ashcroft MT, Serjeant GR. Growth, morbidity and mortality in a cohort of Jamaican adolescents with homozygous sickle cell disease. West Indian Med J 1981 30 : 197 201.
12. Kato GJ, McGowan V, Machado RF et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006 107 : 2279 85.
13. De Montalembert M, Beauvais P, Bachir D et al. Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease. Eur J Pediatr 1993 152 : 201 4.
14. Castro O, Brambilla D, Thorington B et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood 1994 82 : 643 9.
15. Alexander N, Higgs D, Dover G, Serjeant GR. Are there clinical phenotypes of homozygous sickle cell disease? Br J Haematol 2004 17 : 410 16.
16. Downes S, Hambleton I, Chuang E et al. Incidence and natural history of proliferative sickle cell retinopathy. Ophthalmology 2005 112 : 1869 75.
17. Condon PI, Serjeant GR. Ocular findings in homozygous sickle cell anemia in Jamaica. Am J Ophthalmol 1972 73 : 533 43.
18. Milner PF, Kraus AP, Sebes JI et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991 325 : 1476 81.
19. Franks PJ, McCullagh L, Moffatt CJ. Assessing quality of life in patients with chronic leg ulceration using the Medical Outcomes Short Form-36 questionnaire. Ostomy Wound Manage 2003 49 : 26 37.
20. Ribu L, Hanestad BR, Moum T et al. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res 2007 16 : 179 89.
21. Valensi P, Girod I, Baron F et al. Quality of life and clinical correlates in patients with diabetic foot ulcers. Diabetes Metab 2005 31 : 263 71.
22. Myrdal G, Valtysdottir S, Lambe M, Stahle E. Quality of life following lung cancer surgery. Thorax 2003 58 : 194 7.
23. Muller-Nordhorn J, Roll S, Willich SN. Comparison of the Short Form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease. Heart 2004 90 : 523 7.
24. Vasilieva IA. Quality of life in chronic hemodialysis patients in Russia. Hemodial Int 2006 10 : 274 8.
25. Silveira E, Taft C, Sundh V et al. Performance of the SF-36 health survey in screening for depressive and anxiety disorders in an elderly female Swedish population. Qual Life Res 2005 14 : 1263 74.
26. Sampogna F, Tabolli S, Soderfeldt B et al. IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006 154 : 844 9.
27. Powars D, Chan L, Hiti A et al. Outcome of sickle cell anemia. A 4-decade observational study of 1056 patients. Medicine (Baltimore) 2005 84 : 363 76.